Cargando…
The Effect of Low-Dose Naltrexone on Medication in Inflammatory Bowel Disease: A Quasi Experimental Before-and-After Prescription Database Study
BACKGROUND AND AIMS: Low-dose naltrexone [LDN] is a controversial off-label treatment used by many Crohn’s disease [CD] and ulcerative colitis [UC] patients. A small number of preliminary studies indicate that LDN might be beneficial in CD, but evidence is too scarce to demonstrate efficacy. We soug...
Autores principales: | Raknes, Guttorm, Simonsen, Pia, Småbrekke, Lars |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5972567/ https://www.ncbi.nlm.nih.gov/pubmed/29385430 http://dx.doi.org/10.1093/ecco-jcc/jjy008 |
Ejemplares similares
-
Corrigendum: The Effect of Low-Dose Naltrexone on Medication in Inflammatory Bowel Disease: A Quasi Experimental Before-and-After Prescription Database Study
por: Raknes, Guttorm, et al.
Publicado: (2019) -
No change in the consumption of thyroid hormones after starting low dose naltrexone (LDN): a quasi-experimental before-after study
por: Raknes, Guttorm, et al.
Publicado: (2020) -
Low dose naltrexone in multiple sclerosis: Effects on medication use. A quasi-experimental study
por: Raknes, Guttorm, et al.
Publicado: (2017) -
Low dose naltrexone: Effects on medication in rheumatoid and seropositive arthritis. A nationwide register-based controlled quasi-experimental before-after study
por: Raknes, Guttorm, et al.
Publicado: (2019) -
Correction: Low dose naltrexone: Effects on medication in rheumatoid and seropositive arthritis. A nationwide register-based controlled quasi-experimental before-after study
por: Raknes, Guttorm, et al.
Publicado: (2019)